Immunotherapy
6.0
credits/contact hours
Register Now |  Learning Objectives |  Registration Fee |  Agenda |  Accreditation

Learn From the Experts About
Clinical Advances and Case Studies in Immune Checkpoint Inhibitors in Oncology

Learn about the immune system and immune checkpoint targets, as well as everything the oncology AP needs to know about managing immune-related adverse events. 

 

Dallas, TX • September 15, 2018

DoubleTree by Hilton Dallas Campbell Centre
8250 North Central Expressway
Dallas, TX 75206
Register Now

LEARNING OBJECTIVES

Upon completion of this activity, participants will be able to:

  • Differentiate between early and late adverse effects associated with immunotherapeutic agents.
  • Recognize the differences between the immunotherapeutic agents and of chemotherapeutic agents: mechanisms of action, adverse effects, and toxicity management.
  • Summarize data on currently available immunotherapeutic agents as they relate to durable treatment responses.
  • Explain the utility of biomarker testing in selecting patients for immunotherapy and in predicting clinical outcomes.

REGISTRATION

  Member Non-Member
Registration $50.00 $75.00

AGENDA

7:30 am Registration
8:00 am Breakfast
9:00 am Welcome and Introductions
9:15 am Overview of the Immune System and Immune Checkpoint Targets and their MOAs – 0.75 Contact Hour
  • CTLA-4
  • PD-1/PD-L1
  • IDO inhibition and other promising targets
10:00 am Break
10:15 am Treatment-Related Issues – 0.75 Contact Hour
  • Assessment of treatment response
  • Predictive immunotherapy biomarkers
    • Next-generation sequencing
    • Tumor mutation burden
    • Circulating tumor DNA
    • MSI/MMR
  • Combining treatments
    • Immunotherapy plus immunotherapy
    • Immunotherapy plus chemotherapy
    • Immunotherapy plus targeted therapy
11:00 am Management of Immune-Related Adverse Events – 1.00 Contact Hour
  • Overview of immune-related adverse events
  • Dermatitis
  • Arthralgias
  • Hemolytic anemia
  • Autoimmune endocrinopathies
  • Endocrine issues
  • Colitis
  • Pneumonitis
12:00 pm Lunch
1:00 pm Renal Cell Carcinoma – 0.50 Contact Hour
  • Combination immunotherapies and combination IO and chemotherapy
    (CheckMate 9ER, CheckMate 214, KEYNOTE-564, KEYNOTE-426)
1:30 pm Non–Small Cell Lung Cancer – 1.00 Contact Hour
  • Review of clinical trial data (PACIFIC, OAK, CheckMate 057, CheckMate 026, KEYNOTE-024, KEYNOTE-021)
  • Case study
2:30 pm Break
2:40 pm iPad raffle drawing
2:45 pm Melanoma – 0.50 Contact Hour
  • Review of clinical trial data (CheckMate 067, KEYNOTE-006)
  • Case study
3:15 pm Mismatch Repair Deficiency/Microsatellite Instability-High Cancers – 0.50 Contact Hour
  • Review of clinical trial data (KEYNOTE-016, KEYNOTE-164, KEYNOTE-012, KEYNOTE-028, KEYNOTE-158, CheckMate 142)
  • Case study
3:45 pm Head and Neck Cancer – 0.50 Contact Hour
  • Review of clinical trial data (KESTREL, EAGLE, CheckMate 141, KEYNOTE-040)
  • Case study
4:15 pm Urothelial Carcinoma – 0.50 Contact Hour
  • Review of clinical trial data (IMvigor211, KEYNOTE-045, CheckMate 275, JAVELIN, Study 1108)
  • Case study: first-line therapy
  • Case study: second-line therapy
4:45 pm  

*Subject to change

Dallas, TX • September 15, 2018

DoubleTree by Hilton Dallas Campbell Centre
8250 North Central Expressway
Dallas, TX 75206
Register Now

ACCREDITATION


Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower, the Advanced Practitioner Society for Hematology and Oncology, Harborside Medical Education, and the Journal of the Advanced Practitioner in Oncology. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  

Nurses: The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

A maximum of 6.0 contact hours may be earned for successful completion of this activity.

Pharmacists: The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-9999-18-041-L01-P.

This program is designated for up to 6.0 contact hours (0.600 CEUs) of continuing pharmacy education credit.

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.

PAs may receive a maximum of 6.0 Category 1 credits for completing this activity.

This activity is supported by independent educational grants from AstraZeneca and Bristol-Myers Squibb.

This CME/CE/CPE certified conference is jointly provided by
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.